Skip to main content
. 2017 Dec 7;9(3):4258–4266. doi: 10.18632/oncotarget.23101

Table 2. Associations between p62 expression and OS stratified according to the ethnics, case number, NOS score, antibodies and cut-off value.

Categories Subgroups Ref HR (95% CI) Heterogeneity test (I2, P-value)
Ethnics Asian [16, 1924, 26, 27, 2931, 33] 2.69 (2.08–3.48) 37.3%, 0.085
Not Asian [18, 28, 32, 35] 1.48 (1.08–2.04) 39.4%, 0.176
Case Number ≥ 150 [20, 23, 24, 2629, 32, 33, 35] 2.15 (1.69–2.72) 56.5%, 0.014
<150 [16, 18, 19, 21, 22, 30, 31] 2.53 (1.84–3.47) 15.4%, 0.312
NOS Score ≥ 7 [16, 19, 20, 2224, 2629, 32, 33, 35] 2.18 (1.75–2.71) 58.1%, 0.004
<7 [18, 21, 30, 31] 2.61 (1.70–4.00) 0.0%, 0.681
Antibody Santa Cruz [2022, 24, 27, 31] 2.11 (1.50–2.96) 23.5%, 0.258
Abcam [19, 23, 26, 29, 30] 2.77 (1.77–4.32) 9.9%, 0.350
MBL [16, 28, 35] 1.72 (1.20–2.46) 59.3%, 0.086
NR [18, 32, 33] 2.21 (1.47–3.34) 74.2%, 0.021
Cut-off Value IRS [19,2123,26, 27, 29, 30] 2.55 (1.80–3.61) 0.0%, 0.448
Percentage [16, 18, 20, 24, 28, 31, 32, 35] 1.73 (1.34–2.23) 34.9%, 0.150

IRS: Immunoreactive Score; NR: Not Reported.